<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD000978-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD000978-sec-0008"></div> <div class="table" id="CD000978-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Cryotherapy versus no treatment for preventing oral mucositis for patients with cancer receiving treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Cryotherapy versus no treatment for preventing oral mucositis for patients with cancer receiving treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> preventing oral mucositis for patients with cancer receiving treatment<br><b>Settings:</b><br><b>Intervention:</b> Cryotherapy versus no treatment </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>No of Participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Quality of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Control</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Cryotherapy versus no treatment</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (any)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.74</b> <br>(0.57 to 0.95) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>472<br>(5 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>low</b><sup>2,3</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>600 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>444 per 1000</b><br>(342 to 570) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>950 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>703 per 1000</b><br>(541 to 902) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (severe)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>4</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.36</b> <br>(0.17 to 0.77) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>472<br>(5 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>low</b><sup>2,5</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>108 per 1000</b><br>(51 to 231) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>4</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>650 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>234 per 1000</b><br>(111 to 501) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on the range of absolute risk of developing any mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>2</sup> 3 studies at high risk of bias and 2 unclear<br><sup>3</sup> Substantial heterogeneity Chi squared = 14.77, df=4, P=0.005, I squared =73%, <br><sup>4</sup> Based on the range of absolute risk of developing severe mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>5</sup> Substantial heterogeneity Chi squared=14.31, df=4, P=0.006, I squared =72%. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD000978-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span> <span class="table-title">Amifostine versus placebo/no treatment for preventing oral mucositis for patients with cancer receiving treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Amifostine versus placebo/no treatment for preventing oral mucositis for patients with cancer receiving treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> preventing oral mucositis for patients with cancer receiving treatment<br><b>Settings:</b><br><b>Intervention:</b> Amifostine versus placebo/no treatment </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>No of Participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Quality of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Control</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Amifostine versus placebo/no treatment</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (any)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.95</b> <br>(0.91 to 0.99) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>430<br>(3 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>moderate</b><sup>2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>600 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>570 per 1000</b><br>(546 to 594) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>950 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>902 per 1000</b><br>(865 to 941) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (severe)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>3</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.68</b> <br>(0.45 to 1.03) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>845<br>(9 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>4,5,6</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>204 per 1000</b><br>(135 to 309) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>3</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>650 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>442 per 1000</b><br>(292 to 669) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on the range of absolute risk of developing any mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>2</sup> Two trials at high risk of bias and one unclear.<br><sup>3</sup> Based on the range of absolute risk of developing severe mucositis of patients (with different cancer types and treatments) in the control groups of included studies.<br><sup>4</sup> Six trials at high risk of bias and three unclear.<br><sup>5</sup> Substantial heterogeneity, Chi squared 40.39, df=8, P&lt;0..0001, I squared =80% with inconsistency (one trial favouring control)<br><sup>6</sup> Wide confidence intervals, small studies and/or low event rates </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD000978-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span> <span class="table-title">Keratinocyte GF versus placebo for preventing oral mucositis for patients with cancer receiving treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Keratinocyte GF versus placebo for preventing oral mucositis for patients with cancer receiving treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients with preventing oral mucositis for patients with cancer receiving treatment<br><b>Settings:</b><br><b>Intervention:</b> Keratinocyte GF versus placebo </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>No of Participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Quality of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Control</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Keratinocyte GF versus placebo</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (any)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.82</b> <br>(0.71 to 0.94) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>160<br>(2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>low</b><sup>2,3</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>600 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>492 per 1000</b><br>(426 to 564) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>950 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>779 per 1000</b><br>(674 to 893) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (severe)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>4</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.72</b> <br>(0.58 to 0.9) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>559<br>(6 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>low</b><sup>5,6</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>216 per 1000</b><br>(174 to 270) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>4</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>650 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>468 per 1000</b><br>(377 to 585) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on the range of absolute risk of developing any mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>2</sup> Two studies at unclear risk of bias<br><sup>3</sup> Substantial heterogeneity Chi squared =10.11 df=1, P=0.001, I squared =90%.<br><sup>4</sup> Based on the range of absolute risk of developing severe mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>5</sup> One study at high risk of bias and five at unclear risk of bias.<br><sup>6</sup> Moderate heterogeneity Chi squared 10.37, df=5,P=0.07, I squared =52% </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD000978-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span> <span class="table-title">Sucralfate versus placebo/usual care for preventing oral mucositis for patients with cancer receiving treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Sucralfate versus placebo/usual care for preventing oral mucositis for patients with cancer receiving treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> preventing oral mucositis for patients with cancer receiving treatment<br><b>Settings:</b><br><b>Intervention:</b> Sucralfate versus placebo/usual care </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>No of Participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Quality of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Control</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Sucralfate versus placebo/usual care</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (any)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.98</b> <br>(0.88 to 1.1) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>222<br>(3 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>moderate</b><sup>2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>600 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>588 per 1000</b><br>(528 to 660) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>950 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>931 per 1000</b><br>(836 to 1000) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (severe)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>3</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.67</b> <br>(0.48 to 0.92) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>428<br>(7 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>moderate</b><sup>4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>201 per 1000</b><br>(144 to 276) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>3</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>650 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>435 per 1000</b><br>(312 to 598) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on the range of absolute risk of developing any mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>2</sup> All studies at unclear risk of bias<br><sup>3</sup> Based on the range of absolute risk of developing severe mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>4</sup> One study at low risk of bias and six at unclear risk of bias </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD000978-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span> <span class="table-title">Chlorhexidine versus placebo/no treatment for preventing oral mucositis for patients with cancer receiving treatment</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Chlorhexidine versus placebo/no treatment for preventing oral mucositis for patients with cancer receiving treatment</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> preventing oral mucositis for patients with cancer receiving treatment<br><b>Settings:</b><br><b>Intervention:</b> Chlorhexidine versus placebo/no treatment </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>No of Participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Quality of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Control</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Chlorhexidine versus placebo/no treatment</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (any)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>1</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.76</b> <br>(0.47 to 1.24) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>454<br>(4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>low</b><sup>2,3</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>600 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>456 per 1000</b><br>(282 to 744) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>1</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>950 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>722 per 1000</b><br>(446 to 1000) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>Mucositis (severe)</b><br>0‐4 scale<br>Follow‐up: median 28 days </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low risk population<sup>4</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p><b>RR 0.82</b> <br>(0.54 to 1.23) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>244<br>(4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>low</b><sup>5,6</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>246 per 1000</b><br>(162 to 369) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High risk population<sup>4</sup></b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>650 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>533 per 1000</b><br>(351 to 800) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on the range of absolute risk of developing any mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>2</sup> One study at low risk of bias and three unclear.<br><sup>3</sup> Substantial heterogeneity Chi squared 30.49, df=3, P&lt;0.0001, I squared = 90%.<br><sup>4</sup> Based on the range of absolute risk of developing severe mucositis of patients (with different cancer types and treatments) in the control groups of the included studies.<br><sup>5</sup> One high risk of bias, two unclear and one low<br><sup>6</sup> Moderate heterogeneity Chi squared 7.44,df=3, P=0.06, I squared = 60%, with some inconsistency (only one study, at unclear risk of bias, showing benefit) </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
